USD10
OLMA Shares
About Olema PharmaceuticalsOlema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
USD10
OLMA Shares
About Olema PharmaceuticalsOlema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$1B
OPEN PRICE
$10.75
LOW (1Y)
$4.40
HIGH (1Y)
$36.26
LOW (24H)
$10.75
HIGH (24H)
$11.88
VOLUME (24H)
$1.49M
26.55%
Price history
Time | Price | Change |
|---|---|---|
Today | $10.75 | |
1 Day | $11.65 | |
1 Week | $11.78 | |
1 Month | $9.40 | |
1 Year | $4.59 |
Past performance is not a reliable indicator of future results.
Discover more
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.